- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Anthera Pharmaceuticals Inc+ Add to Watchlist
ANTH:US2.8000 USD 0.0200 0.72%
As of 20:10:00 ET on 12/20/2013.
Company Profile for Anthera Pharmaceuticals Inc (ANTH)
Anthera Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing anti-inflammatory therapeutics for cardiovascular diseases, lupus and other serious diseases.
Anthera Pharmaceuticals Inc
Key Executives for Anthera Pharmaceuticals Inc (ANTH)
|Christopher S HenneyChairman||Paul F TruexPresident/CEO/Founder|
|Debra OdinkSenior VP/CTO||Colin HislopSenior VP/Chief Medical Ofcr|
|May LiuSenior VP:Finance & Administration||Paula AdamsVP:Regulatory Affairs|